<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig8">
 <label>Fig. 8</label>
 <caption>
  <p>Erucic acid attenuates excessive pulmonary inflammation upon IAV challenge in vivo. (A) On day 5 p.i., lungs were harvested and homogenized for immunoblot analysis using indicated antibodies. Quantification and normalization of phosphorylated proteins to the internal control GAPDH (right panel). (B–C) Cytokine profiling in BALF (B) and lung homogenates (C) assayed by multiplex analysis. (D) Levels of IFN-α and IFN-β in BALF assayed by Luminex analysis. (E) Levels of IL-10 in lung homogenates assayed by Luminex analysis. Date are presented as the mean ± standard error of the mean. ∗
   <italic>P</italic> &lt; 0.05, ∗∗
   <italic>P</italic> &lt; 0.01 vs. IAV-infected.
  </p>
 </caption>
 <alt-text id="alttext0055">Fig. 8</alt-text>
 <graphic xlink:href="gr8" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
